Connect with us

Announcements

The Arthritis Foundation Releases CBD Guidance for Adults with Chronic Pain

Published

on

The Arthritis Foundation Releases CBD Guidance for Adults with Chronic Pain

Arthritis is a debilitating condition that can make regular tasks all the more difficult. The Arthritis Foundation recently issued a new guidance on CBD, which may help those with the condition.

The blog post on the Arthritis Foundation’s website announcing the guidance indicates that the foundation recently consulted with “leading arthritis and CBD experts” to formulate what users should know about CBD, derived from the hemp plant.

The blog post also indicates that Natalie Azar, M.S., a rheumatologist and medical contributor for NBC news, featured the guidance in her report on the “Today Show” this morning. The guidance, which can be read in full here, indicates that the Arthritis Foundation takes the following position on cannabis:

“We are intrigued by the potential of CBD to help people find pain relief and are on record urging the FDA to expedite the study and regulation of these products. While currently there is limited scientific evidence about CBD’s ability to help ease arthritis symptoms, and no universal quality standards or regulations exist, we have listened to our constituents and consulted with leading experts** to develop these general recommendations for adults who are interested in trying CBD.”

Further, although the guidance recognizes that there is more to learn about CBD, it also notes that there are no quality clinical studies on CBD and arthritis, and doctors have not been able to indicate who may benefit from CBD. Moreover, although CBD is not a substitute for disease-modifying treatment for inflammatory arthritis, those who are interested in CBD should:

“first talk to the health care provider who treats their arthritis before trying CBD. Together, they can review what has worked or not worked in the past, whether there are other options to try first, how to do a trial run, what to watch for and when to return for a follow-up visit to evaluate the results. Keep a symptom and dose diary to track effects.”

All in all, the guidance appears to be an informative piece. Kevin Boehnke, a research investigator who works in anesthesiology at the University of Michigan, who helped develop and write the guidance for the foundation, shared with the Today Show:

“The guidelines are not saying ‎’you should try this.’ They’re saying, ‘if you want to try, here’s how you should do it.’”

Michael is a freelance writer with several years of experience in writing of all kinds. From the uber-technical to the more relaxed, he is well-versed in a variety of styles. Lately, his work has been primarily focused on the CBD industry—a market with which he has a particular background and interest. Michael has an extensive interest and experience in legal research for the CBD market, and he has a knack for well-researched pieces and guides for the growing CBD and medicinal cannabis community.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.